ヘルスケア受託製造開発機関(CDMO)の世界市場2020-2027:サービス別(契約開発、受託製造)、地域別

◆英語タイトル:Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN031
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ヘルスケア受託製造開発機関(CDMO)の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、サービス別(契約開発、受託製造)分析、地域別分析、競争分析など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・ヘルスケア受託製造開発機関(CDMO)の世界市場規模:サービス別(契約開発、受託製造)
・ヘルスケア受託製造開発機関(CDMO)の世界市場規模:地域別
・競争分析
【レポートの概要】

The global healthcare contract development and manufacturing organization market size is expected to reach USD 352.3 billion by 2027, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing outsourcing of R&D is one of the major factors contributing to the market growth.

Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth over the forecast period.

In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to increasing demand for medical devices in the emerging countries, various companies are shifting their focus on research and development and outsourcing of medical devices. Also, rise in outsourcing of R&D and growing competency of CDMOs are expected to further contribute to the growing demand for early stage development CDMOs by life science companies.

However, increasing logistic costs, serialization issues faced by healthcare organizations, and threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.

Further key findings from the report suggest:

• The contract manufacturing segment dominated the market with a revenue share of 72.7% in 2019 due to increase in the outsourcing of manufacturing services by pharmaceutical and medical device companies

• The preclinical segment is expected to register the highest CAGR of 8.6% over the forecast period due to rising prevalence of many lifestyle-influenced diseases

• North America dominated the healthcare contract development and manufacturing organization market with the largest revenue share of 41.2% in 2019 owing to the presence of large number of CROs and CMOs in the region

• The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to low cost service offered by Asian CROs and CMOs

• Some of the key market players are Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil Inc.; Sanmina Corporation; IQVIA Holdings Inc.; and Flex Ltd.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Services
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key service scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Contract Development & Manufacturing Organization Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing outsourcing services by pharmaceutical companies
3.4.1.2. Rising investment in R&D
3.4.1.3. Growing pharmaceutical industry
3.4.1.4. Increasing demand for one-stop-shop CDMOs
3.4.2. Market Restraint Analysis
3.4.2.1. Compliance issues while outsourcing
3.4.2.2. Changing scenarios in developing countries
3.4.2.3. Regulatory and legal compliance
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Healthcare Contract Development & Manufacturing Organization: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Healthcare Contract Development & Manufacturing Organization Market : Segment Analysis, by Services, 2016 – 2027 (USD Billion)
4.1. Definitions & Scope
4.2. Service market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Healthcare Contract Development & Manufacturing Organization Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Contract Development
4.5.1.1 Preclinical
4.5.1.1.1 Bioanalysis and DMPK studies
4.5.1.1.2 Toxicology Testing
4.5.1.1.3 Other Preclinical Services
4.5.1.2 Clinical
4.5.1.2.1 Phase I
4.5.1.2.2 Phase II
4.5.1.2.3 Phase III
4.5.1.2.4 Phase IV
4.5.1.3 Laboratory Services
4.5.1.3.1 Bioanalytical Services
4.5.1.3.2 Analytical Services
4.5.2. Contract Manufacturing
4.5.2.1 API/Bulk Drugs
4.5.2.2 Finished Dose Formulations
4.5.2.3 Medical Device
4.5.2.3.1 Class I
4.5.2.3.2 Class II
4.5.2.3.3 Class III
Chapter 5. Healthcare Contract Development & Manufacturing Organization Market : Regional Market Analysis, By Region, 2016 – 2027 (USD Billion)
5.1. Definitions & Scope
5.2. Regional Market Share Analysis, 2019 & 2027
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot
5.5. Regional Market Share, 2018
5.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
5.7. North America
5.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Billion)
5.7.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.7.3. U.S.
5.7.3.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.7.4. Canada
5.7.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8. Europe
5.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Billion)
5.8.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.3. Germany
5.8.3.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.4. U.K.
5.8.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.5. France
5.8.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.6. Italy
5.8.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.7. Spain
5.8.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.8. Netherlands
5.8.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.9. Belgium
5.8.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.10. Switzerland
5.8.10.1. Market estimates and forecast, by Services, 2016 – USD Billion)
5.8.11. Russia
5.8.11.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.8.12. Sweden
5.8.12.1 Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9. Asia Pacific
5.9.1. Market estimates and forecast, by country, 2016 – 2027 (USD Billion)
5.9.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.3. China
5.9.3.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.4. Japan
5.9.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.5. India
5.9.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.6. Australia
5.9.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.7. South Korea
5.9.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.8. Malaysia
5.9.8.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.9. New Zealand
5.9.9.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.10. Singapore
5.9.10.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.11. Philippines
5.9.11.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.9.12. Thailand
5.9.12.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10. Latin America
5.10.1. Market estimates and forecast, by country, 2016 – 2027 (USD Billion)
5.10.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10.3. Brazil
5.10.3.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10.4. Mexico
5.10.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10.5. Argentina
5.10.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10.6. Colombia
5.10.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.10.7. Chile
5.10.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11. Middle East and Africa
5.11.1. Market estimates and forecast, by country, 2016 – 2027 (USD Billion)
5.11.2. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11.3. South Africa
5.11.3.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11.4. Saudi Arabia
5.11.4.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11.5. UAE
5.11.5.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11.6. Israel
5.11.6.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
5.11.7. Egypt
5.11.7.1. Market estimates and forecast, by Services, 2016 – 2027 (USD Billion)
Chapter 6. Healthcare Contract Development & Manufacturing Organization Market – Competitive Analysis
6.1. Key companies profiled
6.1.1. Catalent Inc.
6.1.1.1. Company Overview
6.1.1.2. Financial Performance
6.1.1.3. Product Benchmarking
6.1.1.4. Strategic Initiatives
6.1.2. Lonza Group Ltd.
6.1.2.1. Company Overview
6.1.2.2. Financial Performance
6.1.2.3. Product Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Recipharm AB
6.1.3.1. Company Overview
6.1.3.2. Financial Performance
6.1.3.3. Product Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. Siegfried Holding AG
6.1.4.1. Company Overview
6.1.4.2. Financial Performance
6.1.4.3. Product Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. Thermo Fisher Scientific Inc.
6.1.5.1. Company Overview
6.1.5.2. Financial Performance
6.1.5.3. Product Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. Covance Inc.
6.1.6.1. Company Overview
6.1.6.2. Financial Performance
6.1.6.3. Product Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. Jabil
6.1.7.1. Company Overview
6.1.7.2. Financial Performance
6.1.7.3. Product Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. Sanmina Corporation
6.1.8.1. Company Overview
6.1.8.2. Financial Performance
6.1.8.3. Product Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. IQVIA Holdings Inc.
6.1.9.1. Company Overview
6.1.9.2. Financial Performance
6.1.9.3. Product Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. Flex
6.1.10.1. Company Overview
6.1.10.2. Financial Performance
6.1.10.3. Product Benchmarking
6.1.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare Contract Development & Manufacturing Organization Market, By Region 2016 - 2027 (USD Billion)
Table 4 Global Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 5 North America Healthcare Contract Development & Manufacturing Organization Market, By Country, 2016 - 2027 (USD Billion)
Table 6 North America Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 7 U.S. Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 8 Canada Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 9 Europe Healthcare Contract Development & Manufacturing Organization Market, By Country, 2016 - 2027 (USD Billion)
Table 10 Europe Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 11 U.K. Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 12 Germany Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 13 France Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 14 Italy Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 15 Spain Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 16 Netherlands Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 17 Belgium Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 18 Switzerland Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 19 Russia Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 20 Sweden Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 21 Asia Pacific Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 22 China Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 23 Japan Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 24 India Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 25 Australia Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 26 South Korea Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 27 Malaysia Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 28 New Zealand Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 29 Singapore Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 30 Philippines Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 31 Thailand Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 32 Latin America Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 33 Brazil Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 34 Mexico Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 35 Argentina Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 36 Colombia Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 37 Chile Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 38 Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 39 South Africa Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 40 Saudi Arabia Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 41 UAE Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 42 Israel Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)
Table 43 Egypt Healthcare Contract Development & Manufacturing Organization Market, By Services, 2016 - 2027 (USD Billion)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヘルスケア受託製造開発機関(CDMO)の世界市場2020-2027:サービス別(契約開発、受託製造)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆